Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TELA Bio (TELA) FCF Margin (2018 - 2025)

TELA Bio has reported FCF Margin over the past 8 years, most recently at 23.77% for Q4 2025.

  • Quarterly results put FCF Margin at 23.77% for Q4 2025, up 2039.0% from a year ago — trailing twelve months through Dec 2025 was 35.71% (up 2574.0% YoY), and the annual figure for FY2025 was 35.71%, up 2574.0%.
  • FCF Margin for Q4 2025 was 23.77% at TELA Bio, up from 28.66% in the prior quarter.
  • Over the last five years, FCF Margin for TELA hit a ceiling of 23.77% in Q4 2025 and a floor of 146.45% in Q1 2021.
  • Median FCF Margin over the past 5 years was 71.63% (2021), compared with a mean of 75.53%.
  • Biggest five-year swings in FCF Margin: skyrocketed 10709bps in 2021 and later tumbled -3864bps in 2022.
  • TELA Bio's FCF Margin stood at 112.44% in 2021, then grew by 16bps to 94.49% in 2022, then grew by 30bps to 66.22% in 2023, then skyrocketed by 33bps to 44.17% in 2024, then skyrocketed by 46bps to 23.77% in 2025.
  • The last three reported values for FCF Margin were 23.77% (Q4 2025), 28.66% (Q3 2025), and 39.7% (Q2 2025) per Business Quant data.